Literature DB >> 17200196

FasL and TRAIL induce epidermal apoptosis and skin ulceration upon exposure to Leishmania major.

Liv Eidsmo1, Caroline Fluur, Bence Rethi, Sofia Eriksson Ygberg, Nicolas Ruffin, Angelo De Milito, Hannah Akuffo, Francesca Chiodi.   

Abstract

Receptor-mediated apoptosis is proposed as an important regulator of keratinocyte homeostasis in human epidermis. We have previously reported that Fas/FasL interactions in epidermis are altered during cutaneous leishmaniasis (CL) and that keratinocyte death through apoptosis may play a pathogenic role for skin ulceration. To further investigate the alterations of apoptosis during CL, a keratinocyte cell line (HaCaT) and primary human epidermal keratinocytes were incubated with supernatants from Leishmania major-infected peripheral blood mononuclear cells. An apoptosis-specific microarray was used to assess mRNA expression in HaCaT cells exposed to supernatants derived from L. major-infected cultures. Fas and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mRNA and protein expression were significantly up-regulated, and apoptosis was detected in both HaCaT and human epidermal keratinocyte cells. The keratinocyte apoptosis was partly inhibited through blocking of Fas or FasL and even more efficiently through TRAIL neutralization. Up-regulation of Fas on keratinocytes in epidermis and the presence of FasL-expressing macrophages and T cells in dermis were previously reported by us. In this study, keratinocytes expressing TRAIL, as well as the proapoptotic receptor TRAIL-R2, were detected in skin biopsies from CL cases. We propose that activation of Fas and TRAIL apoptosis pathways, in the presence of inflammatory mediators at the site of infection, leads to tissue destruction and ulceration during CL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17200196      PMCID: PMC1762690          DOI: 10.2353/ajpath.2007.060068

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

1.  Apoptosis in proliferating, senescent, and immortalized keratinocytes.

Authors:  V Chaturvedi; J Z Qin; M F Denning; D Choubey; M O Diaz; B J Nickoloff
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

Review 2.  Death receptor signaling.

Authors:  Inna Lavrik; Alexander Golks; Peter H Krammer
Journal:  J Cell Sci       Date:  2005-01-15       Impact factor: 5.285

Review 3.  The RIP kinases: crucial integrators of cellular stress.

Authors:  Etienne Meylan; Jürg Tschopp
Journal:  Trends Biochem Sci       Date:  2005-03       Impact factor: 13.807

4.  Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand.

Authors:  M Jo; T H Kim; D W Seol; J E Esplen; K Dorko; T R Billiar; S C Strom
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

5.  Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma.

Authors:  M S Shin; W S Park; S Y Kim; H S Kim; S J Kang; K Y Song; J Y Park; S M Dong; J H Pi; R R Oh; J Y Lee; N J Yoo; S H Lee
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

6.  Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling.

Authors:  Robert F Kelley; Klara Totpal; Stephanie H Lindstrom; Mary Mathieu; Karen Billeci; Laura Deforge; Roger Pai; Sarah G Hymowitz; Avi Ashkenazi
Journal:  J Biol Chem       Date:  2004-11-01       Impact factor: 5.157

7.  TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells.

Authors:  Jean-Philippe Herbeuval; Adriano Boasso; Jean-Charles Grivel; Andrew W Hardy; Stephanie A Anderson; Matthew J Dolan; Claire Chougnet; Jeffrey D Lifson; Gene M Shearer
Journal:  Blood       Date:  2004-12-07       Impact factor: 22.113

8.  Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity.

Authors:  N Kayagaki; N Yamaguchi; M Nakayama; A Kawasaki; H Akiba; K Okumura; H Yagita
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

9.  TRAIL inhibits tumor growth but is nontoxic to human hepatocytes in chimeric mice.

Authors:  Chunhai Hao; Jin H Song; Belinda Hsi; Jamie Lewis; Doyoun K Song; Kenneth C Petruk; David L J Tyrrell; Norman M Kneteman
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

10.  UVB-induced apoptosis in normal human keratinocytes: role of the erbB receptor family.

Authors:  Davina A Lewis; Steven A Hurwitz; Dan F Spandau
Journal:  Exp Cell Res       Date:  2003-04-01       Impact factor: 3.905

View more
  13 in total

1.  Inhibition of mTORC2 enhances UVB-induced apoptosis in keratinocytes through a mechanism dependent on the FOXO3a transcriptional target NOXA but independent of TRAIL.

Authors:  Robert P Feehan; Amanda M Nelson; Lisa M Shantz
Journal:  Cell Signal       Date:  2018-08-30       Impact factor: 4.315

2.  Mitochondrial superoxide mediates doxorubicin-induced keratinocyte apoptosis through oxidative modification of ERK and Bcl-2 ubiquitination.

Authors:  Sudjit Luanpitpong; Pithi Chanvorachote; Ubonthip Nimmannit; Stephen S Leonard; Christian Stehlik; Liying Wang; Yon Rojanasakul
Journal:  Biochem Pharmacol       Date:  2012-03-24       Impact factor: 5.858

3.  Oxidative stress mediates chemical hypoxia-induced injury and inflammation by activating NF-κb-COX-2 pathway in HaCaT cells.

Authors:  Chuntao Yang; Hongzhong Ling; Meifen Zhang; Zhanli Yang; Xiuyu Wang; Fanqin Zeng; Chuhuai Wang; Jianqiang Feng
Journal:  Mol Cells       Date:  2011-04-20       Impact factor: 5.034

4.  Differential Activation of Human Keratinocytes by Leishmania Species Causing Localized or Disseminated Disease.

Authors:  Breanna M Scorza; Mark A Wacker; Kelly Messingham; Peter Kim; Aloysius Klingelhutz; Janet Fairley; Mary E Wilson
Journal:  J Invest Dermatol       Date:  2017-06-22       Impact factor: 8.551

5.  Induction of TRAIL- and TNF-alpha-dependent apoptosis in human monocyte-derived dendritic cells by microfilariae of Brugia malayi.

Authors:  Roshanak Tolouei Semnani; Priyanka Goel Venugopal; Lily Mahapatra; Jason A Skinner; Francoise Meylan; Daniel Chien; David W Dorward; Damien Chaussabel; Richard M Siegel; Thomas B Nutman
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

6.  Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration.

Authors:  Geremew Tasew; Susanne Nylén; Thorsten Lieke; Befekadu Lemu; Hailu Meless; Nicolas Ruffin; Dawit Wolday; Abraham Asseffa; Hideo Yagita; Sven Britton; Hannah Akuffo; Francesca Chiodi; Liv Eidsmo
Journal:  PLoS Negl Trop Dis       Date:  2010-10-12

7.  Enhanced effector function of CD8(+) T cells from healthy controls and HIV-infected patients occurs through thrombin activation of protease-activated receptor 1.

Authors:  Amanda Hurley; Mindy Smith; Tatiana Karpova; Rebecca B Hasley; Natalya Belkina; Stephen Shaw; Nariman Balenga; Kirk M Druey; Erin Nickel; Beverly Packard; Hiromi Imamichi; Zonghui Hu; Dean Follmann; James McNally; Jeanette Higgins; Michael Sneller; H Clifford Lane; Marta Catalfamo
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

8.  TLR2 Signaling in Skin Nonhematopoietic Cells Induces Early Neutrophil Recruitment in Response to Leishmania major Infection.

Authors:  Catherine Ronet; Katiuska Passelli; Mélanie Charmoy; Leo Scarpellino; Elmarie Myburgh; Yazmin Hauyon La Torre; Salvatore Turco; Jeremy C Mottram; Nicolas Fasel; Sanjiv A Luther; Stephen M Beverley; Pascal Launois; Fabienne Tacchini-Cottier
Journal:  J Invest Dermatol       Date:  2018-12-27       Impact factor: 8.551

9.  FasL and TRAIL signaling in the skin during cutaneous leishmaniasis - implications for tissue immunopathology and infectious control.

Authors:  Bence Rethi; Liv Eidsmo
Journal:  Front Immunol       Date:  2012-06-19       Impact factor: 7.561

Review 10.  TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications.

Authors:  Paolo Perri; Giorgio Zauli; Arianna Gonelli; Daniela Milani; Claudio Celeghini; Giuseppe Lamberti; Paola Secchiero
Journal:  Biomed Res Int       Date:  2015-03-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.